AstraZeneca (AZN) Tops Q1 EPS by 3c; Revs Light
Tweet Send to a FriendGet Alerts AZN Hot Sheet
Trade AZN Now!
AstraZeneca (NYSE: AZN) reported Q1 EPS of $1.81, $0.03 better than the analyst estimate of $1.78. Revenue for the quarter came in at $7.35 billion versus the consensus estimate of $7.85 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
- Micron Technology, Inc. (MU) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
